NewsPrismaUS, UK, Canada & Australia news, compared across the papers
LIVE
Health

Syngenis joins WA research heavyweights in RNA medicine push

Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

Covered by 2 sources from Australia. First reported by The Sydney Morning Herald ·

How 2 newspapers cover this story

  1. The Sydney Morning HeraldAustraliaFirst report

    Syngenis joins WA research heavyweights in RNA medicine push

    Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

  2. The AgeAustralia

    Syngenis joins WA research heavyweights in RNA medicine push

    Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

Coverage details

2 outlets from Australia are covering this story: The Sydney Morning Herald and The Age. The Sydney Morning Herald and The Age published it almost at the same time, on November 19, 2026.

Key names in the coverage: Syngenis Labs, RNA and ASX.

More news from November 19, 2026 →

Related stories